Altered functional connectivity architecture of the brain in medication overuse headache using resting state fMRI

Table 1 The clinical characteristics of MOH patients and NCs

	MOH	EM	NC	F(T) value	P value
Num(F/M)	37(30/7)	18(14/4)	32(20/12)
Age	41.27 ± 9.27	33.39 ± 10.69	41.34 ± 10.89	4.13	0.02
HAMA*	18.35 ± 8.65	15.67 ± 9.85	10.19 ± 2.98	10.56	0.00
HAMD*	20.03 ± 12.68	10.89 ± 7.26	8.03 ± 4.34	17.40	0.00
MoCA*	23.08 ± 3.80	29.17 ± 1.47	27.16 ± 2.32	31.22	0.00
DD(yrs)*	18.57 ± 9..08	12.44 ± 8.07	NA	2.00	0.02
VAS	8.16 ± 1.57	8.33 ± 1.50	NA	2.00	0.70
MIDAS*	124.43 ± 72.62	16 ± 17.94	NA	2.00	0.00

*There was significant difference among each group (P < 0.05)
MOH medication overuse headache, NC normal control, HAMA Hamilton Anxiety Scale, HAMD Hamilton Depression Scale, MoCA Montreal Cognitive Assessment, DD disease duration, VAS Visual Analogue Scale, MIDAS Migraine Disability Assessment questionnaire, NA not available

ISSN: 1129-2377